This study describes the characterizes of a lncRNA HCP5‐derived microprotein, HCP5‐132aa, which exhibits an onco‐promotion effect and presents a prospective therapeutic target for the treatment of gastric cancer. The gene discussed is HCP5; the disease is gastric cancer.